Michael N. Hall

Michael N Hall 2014

Michael N. Hall is a prominent Swiss-American molecular biologist renowned for his groundbreaking research in the field of cell biology. He is best known for his discovery of the Target of Rapamycin (TOR) proteins, which play a crucial role in regulating cell growth and metabolism.

Early Life and Education

Michael N. Hall was born in Puerto Rico and raised in South America. He completed his undergraduate studies at the University of North Carolina at Chapel Hill, where he earned a Bachelor of Science degree in Zoology. He then pursued his Ph.D. in Molecular Genetics at Harvard University under the mentorship of Walter Gilbert, a Nobel Prize laureate.

Career

After completing his Ph.D., Hall conducted postdoctoral research at the Pasteur Institute in Paris, where he worked with Jeffrey Gordon. In 1987, he joined the faculty of the Biozentrum University of Basel in Switzerland, where he has been a professor ever since.

Research and Discoveries

Michael N. Hall's most significant contribution to science is the discovery of the TOR proteins, which are central components of the TOR signaling pathway. This pathway is essential for regulating cell growth, proliferation, and survival in response to nutrients, growth factors, and other environmental cues. The TOR proteins are highly conserved across species, from yeast to humans.

Hall's research has had profound implications for understanding various biological processes and diseases, including cancer, diabetes, and neurodegenerative disorders. His work has also paved the way for the development of new therapeutic strategies targeting the TOR pathway.

Awards and Honors

Michael N. Hall has received numerous awards and honors for his contributions to science, including:

• The Louis-Jeantet Prize for Medicine (2009)
• The Albert Lasker Award for Basic Medical Research (2017)
• The Breakthrough Prize in Life Sciences (2014)
• The Canada Gairdner International Award (2015)

Personal Life

Michael N. Hall is married and has two children. He continues to reside in Basel, Switzerland, where he actively engages in research and mentoring young scientists.

See Also

• Target of Rapamycin
• TOR signaling pathway
• Biozentrum University of Basel
• Louis-Jeantet Prize for Medicine
• Albert Lasker Award for Basic Medical Research
• Breakthrough Prize in Life Sciences
• Canada Gairdner International Award

External Links

‎